Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07135505 · ClinicalTrials.gov registry record · NA

Early Time-Restricted Eating in Older Adults With Hypertension

A NA study of Hypertension and Eating Behaviors, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07135505: Recruiting NA study of Hypertension and Eating Behaviors, sponsored by University of Alabama at Birmingham.

NCT07135505 is a NA study of Hypertension and Eating Behaviors that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07135505, a NA study of Hypertension and Eating Behaviors, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out how early time-restricted eating affects body rhythms and improves cardiometabolic health in older adults.

Primary Outcome

measured by the continuous glucose monitor

Interventions

  • BEHAVIORAL Early time-restricted eating

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-02-16
Est. Completion 2026-12-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT07135505 shows while recruiting

NCT07135505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Early time-restricted eating is the first listed.

NCT07135505 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT07135505 about?

NCT07135505 is a clinical study titled "Early Time-Restricted Eating in Older Adults With Hypertension". The purpose of this study is to find out how early time-restricted eating affects body rhythms and improves cardiometabolic health in older adults.

What is the current status of trial NCT07135505?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-16. Estimated completion is 2026-12-31.

What conditions does trial NCT07135505 study?

This clinical trial studies the following conditions: Hypertension, Eating Behaviors.

What interventions are being tested in trial NCT07135505?

The interventions under investigation include: Early time-restricted eating (BEHAVIORAL).

Who is sponsoring clinical trial NCT07135505?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07135505 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07135505's enrollment target sits among peer trials

30 408th of 470 higher than 54 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07135505, the US trial registry maintained by the National Library of Medicine. NCT07135505 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.